Division of Surgery, General Surgery, Department of Surgery, Tripler Army Medical Center, 1 Jarrett White Road, Honolulu, HI, 96859, USA.
Department of General Surgery, Emory University School of Medicine, 201 Dowman Drive, Atlanta, GA, 30322, USA.
Surg Endosc. 2024 May;38(5):2475-2482. doi: 10.1007/s00464-024-10727-9. Epub 2024 Mar 8.
The most feared complication during laparoscopic cholecystectomy remains a bile duct injury (BDI). Accurately risk-stratifying patients for a BDI remains difficult and imprecise. This study evaluated if the lethal triad of acute cholecystitis, obesity, and steatohepatitis is a prognostic measure for BDI.
A retrospective review of the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) registry was performed. All laparoscopic cholecystectomy cases within the main NSQIP database for 2012-2019 were queried. Two study cohorts were constructed. One with the lethal triad of acute cholecystitis, BMI ≥ 30, and steatohepatitis. The other cohort did not have the full triad present. Multivariate analysis was performed via logistic regression modeling with calculation of odds ratios (OR) to identify independent factors for BDI. An uncontrolled and controlled propensity score match analysis was performed.
A total of 387,501 cases were analyzed. 36,887 cases contained the lethal triad, the remaining 350,614 cases did not have the full triad. 860 BDIs were identified resulting in an overall incidence rate 0.22%. There were 541 BDIs within the lethal triad group with 319 BDIs in the other cohort and an incidence rate of 1.49% vs 0.09% (P < 0.001). Multivariate analysis identified the lethal triad as an independent risk factor for a BDI by over 15-fold (OR 16.35, 95%CI 14.28-18.78, P < 0.0001) on the uncontrolled analysis. For the controlled propensity score match there were 29,803 equivalent pairs identified between the cohorts. The BDI incidence rate remained significantly higher with lethal triad cases at 1.65% vs 0.04% (P < 0.001). The lethal triad was an even more significant independent risk factor for BDI on the controlled analysis (OR 40.13, 95%CI 7.05-356.59, P < 0.0001).
The lethal triad of acute cholecystitis, obesity, and steatohepatitis significantly increases the risk of a BDI. This prognostic measure can help better counsel patients and potentially alter management.
腹腔镜胆囊切除术最可怕的并发症仍然是胆管损伤(BDI)。准确地对 BDI 患者进行风险分层仍然很困难且不准确。本研究评估了急性胆囊炎、肥胖和脂肪性肝炎的致命三联征是否是 BDI 的预后指标。
对美国外科医师学院国家外科质量改进计划(NSQIP)登记处进行了回顾性研究。对 2012 年至 2019 年主要 NSQIP 数据库中的所有腹腔镜胆囊切除术病例进行了查询。构建了两个研究队列。一个是急性胆囊炎、BMI≥30 和脂肪性肝炎的致命三联征。另一个队列没有完整的三联征。通过逻辑回归模型进行多变量分析,并计算比值比(OR)来确定 BDI 的独立因素。进行了未控制和控制倾向评分匹配分析。
共分析了 387501 例病例。36887 例病例存在致命三联征,其余 350614 例病例没有完整三联征。共发现 860 例 BDI,总发生率为 0.22%。致命三联征组中有 541 例 BDI,其他组中有 319 例 BDI,发生率分别为 1.49%和 0.09%(P<0.001)。多变量分析表明,致命三联征是 BDI 的独立危险因素,未控制分析中比值比为 16.35(95%CI 14.28-18.78,P<0.0001)。在控制倾向评分匹配中,两组之间确定了 29803 对等效对。致命三联征组的 BDI 发生率仍显著较高,为 1.65%,而对照组为 0.04%(P<0.001)。在控制分析中,致命三联征是 BDI 的更显著独立危险因素(OR 40.13,95%CI 7.05-356.59,P<0.0001)。
急性胆囊炎、肥胖和脂肪性肝炎的致命三联征显著增加了 BDI 的风险。这种预后指标可以帮助更好地为患者提供咨询,并可能改变治疗方法。